Retraction notice to "30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)": [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428].

Authors :: Shi Y
Wu L
Yu X
Xing P
Zhou J
Wang A
Shi J
Hu Y
Wang Z
An G
Fang Y
Sun S
Zhou C
Wang C
Ye F
Li X
Wang J
Wang M
Liu Y
Zhao Y
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Apr; Vol. 32 (4), pp. 576.
Publication Year :: 2021
Abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.<br /> (Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.)

Language :: English
ISSN :: 1569-8041
Volume :: 32
Issue :: 4
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Accession number :: 33736838
Full Text :: https://doi.org/10.1016/j.annonc.2021.01.009

Full Text Access

Tools